Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.69T
24h Vol:
$10.68B
Dominance:
MSFT:4.75%
Stocklytics Platform
Asset logo  NUWE
Nuwellis
NUWE
56 / 100
Penny Stock
$0.25arrow_drop_up12.04%$0.02

Performance History

Stocklytics logo
Key Stats
Open$0.24
Prev. Close$0.25
EPS-11.52
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap3840359.00
PE Ratio-
LOWHIGH
Day Range0.23
0.25
52 Week Range0.13
3.83
Ratios
P/B Ratio0.83
Revenue-
Operating M. %-255.74%
Earnings$0.00
Earnings Growth %-39.13%
EBITDA Margin %-182.49%
ROE %-248.15%
EPS-11.52

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$763.97
24H (%)arrow_drop_up0.82%
24H ($)$6.27
MARKET CAP$722.30B
PRICE$513.88
24H (%)arrow_drop_up0.41%
24H ($)$2.14
MARKET CAP$471.98B
PRICE$151.38
24H (%)arrow_drop_up0.10%
24H ($)$0.16
MARKET CAP$360.78B
PRICE$128.66
24H (%)arrow_drop_down0.48%
24H ($)-$0.62
MARKET CAP$329.41B

About Nuwellis (NUWE)

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Nestor Jaramillo Jr.
Headquarters
Eden Prairie
Employees
70
Exchange
NASDAQ
add Nuwellis to watchlist

Keep an eye on Nuwellis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the market capitalization of Nuwellis (NUWE)?

Nuwellis (NUWE) has a market capitalization of $3.84M. The average daily trading volume is 26.43M, indicating the stock's liquidity and investor engagement.

help
What is Nuwellis's (NUWE) price per share?

The current price per share for Nuwellis (NUWE) is $0.23. The stock has seen a price change of -$0.02 recently, indicating a -8% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Nuwellis (NUWE)?

For Nuwellis (NUWE), the 52-week high is $3.83, which is 1.57K% from the current price. The 52-week low is $0.13, the current price is 76.92% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Nuwellis (NUWE) a growth stock?

Nuwellis (NUWE) has shown an average price growth of 0.41% over the past three years. It has received a score of -7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nuwellis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Nuwellis (NUWE) stock price performance year to date (YTD)?

As of the latest data, Nuwellis (NUWE) has a year-to-date price change of -66.67%. Over the past month, the stock has experienced a price change of -37.53%. Over the last three months, the change has been -51.06%. Over the past six months, the figure is -61.67%.

help
Is Nuwellis (NUWE) a profitable company?

Nuwellis (NUWE) has a net income of -$20.21M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.22% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -255.74% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 3.76%, providing insight into the company's sales performance and growth. The gross profit is $4.98M. Operating income is noted at -$17.63M. Furthermore, the EBITDA is -$16.18M.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level